Platinol-AQ Interactions
There are 461 drugs known to interact with Platinol-AQ (cisplatin), along with 7 disease interactions. Of the total drug interactions, 89 are major, 353 are moderate, and 19 are minor.
- View all 461 medications that may interact with Platinol-AQ
- View Platinol-AQ disease interactions (7)
Most frequently checked interactions
View interaction reports for Platinol-AQ (cisplatin) and the medicines listed below.
- Actemra (tocilizumab)
- Actemra (tocilizumab)
- Amicar (aminocaproic acid)
- Amicar (aminocaproic acid)
- Aricept (donepezil)
- Aricept (donepezil)
- Avastin (bevacizumab)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Blincyto (blinatumomab)
- Cresemba (isavuconazonium)
- Cresemba (isavuconazonium)
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- Diflucan (fluconazole)
- Diflucan (fluconazole)
- Epidiolex (cannabidiol)
- Epidiolex (cannabidiol)
- Farydak (panobinostat)
- Farydak (panobinostat)
- Imbruvica (ibrutinib)
- Imbruvica (ibrutinib)
- Imlygic (talimogene laherparepvec)
- Imlygic (talimogene laherparepvec)
- Isentress (raltegravir)
- Isentress (raltegravir)
Platinol-AQ disease interactions
There are 7 disease interactions with Platinol-AQ (cisplatin) which include:
- infections
- hearing loss
- myelosuppression
- peripheral neuropathy
- renal dysfunction
- hemolytic anemia
- ocular toxicity
Report options
More about Platinol-AQ (cisplatin)
- Platinol-AQ consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.